-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Recent advances in treatment of metastatic colorectal cancer
Sigurdis Haraldsdottir & Richard M Goldberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Recent advances in treatment of metastatic colorectal cancer
Sigurdis Haraldsdottir & Richard M Goldberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Recent advances in treatment of metastatic colorectal cancer
Sigurdis Haraldsdottir & Richard M Goldberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Recent advances in treatment of metastatic colorectal cancer
Sigurdis Haraldsdottir & Richard M Goldberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Recent advances in treatment of metastatic colorectal cancer
Sigurdis Haraldsdottir & Richard M Goldberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Recent advances in treatment of metastatic colorectal cancer
Sigurdis Haraldsdottir & Richard M Goldberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation